Mar 13, 2017 11:35 am UTC| Business
DEVON, Pa., March 13, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today...
Mar 13, 2017 11:34 am UTC| Business
LONDON, March 13, 2017 -- Dr. Philip Comberg, chief executive officer and Carl Weatherley-White, chief financial officer of VivoPower International PLC (“VivoPower”) (NASDAQ:VVPR), are scheduled to present and...
ParkerVision Filing Motion to Terminate ITC Investigation Following Ruling to Disallow Key Evidence
Mar 13, 2017 11:31 am UTC| Business
JACKSONVILLE, Fla., March 13, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that in light of a recent ruling by the...
ParkerVision Filing Motion to Terminate ITC Investigation Following Ruling to Disallow Key Evidence
Mar 13, 2017 11:31 am UTC| Business
JACKSONVILLE, Fla., March 13, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that in light of a recent ruling by the...
Parker Hannifin Celebrates 100 Years
Mar 13, 2017 11:31 am UTC| Business
CLEVELAND, March 13, 2017 -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today is celebrating the 100th anniversary of its founding on March 13, 1917 and has launched a...
Parker Hannifin Celebrates 100 Years
Mar 13, 2017 11:31 am UTC| Business
CLEVELAND, March 13, 2017 -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today is celebrating the 100th anniversary of its founding on March 13, 1917 and has launched a...
Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 13, 2017 11:31 am UTC| Business
– Opened two new INDs for wholly-owned SPEAR® T-cell therapies; Company now has four open INDs in 11 indications – – Received orphan designation, PRIME regulatory support and Breakthrough Therapy designation for NY-ESO...